ABCB6 and cancer: Therefore, the simultaneous administration of an efficient ABC-efflux modulator/inhibitor with chemotherapeutic agents has been proposed as a powerful therapeutic strategy to overcome MDR by re-establishing the drug sensitivity of resistant cancer cells or improving the pharmacokinetics of anti-cancer agents in order to achieve better therapeutic outcomes in cancer patients.